A Day Up For PaxMedica Inc.
Fri, Nov 18, 2022 at 07:27 PM
PaxMedica Inc. (PXMD:NASDAQ) rocketted at $2.13, a gain of 37.4%. On Fri, Nov 18, 2022, PXMD:NASDAQ touched a New 2-Week High of $2.13. The stock appeared on our News Catalysts scanner on Thu, Nov 17, 2022 at 09:11 PM in the 'AGREEMENT' category. From Mon, Nov 07, 2022, the stock recorded 55.56% Up Days and 30.00% Green Days
About PaxMedica Inc. (PXMD:NASDAQ)
PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism...
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 91.67%
- AGBA Acquisition Limited (AGBA:NASDAQ), 50.67%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 46.85%
- PaxMedica Inc. (PXMD:NASDAQ), 37.42%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 32.91%
- Yatra Online, Inc. (YTRA:NASDAQ), 32.55%
- XL Group Ltd (XL:NYSE), 30.91%
- Stryve Foods Inc. (SNAX:NASDAQ), 28.62%
- Conformis, Inc. (CFMS:NASDAQ), 28.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%